Market Date:19 September, 2020

Outrage After Australian Medical Cannabis Connected Raids

Australia’s Medical Cannabis Users Association (MCUA) has condemned recent raids in the homes of fellow activists from the state of  Queensland.

Based on MCUA, the house of 66 year-old handicap pensioner Maggie O’Rance was raided on Wednesday. After supposedly locating a gram of cannabis and a pipe, Ms O’Rance was charged by authorities with associated offences.

MCUA states Ms. O’Rance was attempting to find a prescription for cannabis but was unable to and turned into the black market.

Also on this day, the house of cannabis teacher and advocate Dr. Deb Waldron was allegedly raided, but there were not any additional details on the actions or if any charges had been set.

“These kinds of police actions cost the tax payers thousands of dollars and for what benefit,” stated MCUA President Deb Lynch. “They are not in the public interest and they need to stop making criminals out of patients.”

MCUA says there must be a moratorium on arrests while a Federal Senate query to obstacles to individual access is under way. Cannabis was made legal for medical use in Australia in 2016, but the procedure for accessibility remains complicated and the goods expensive; placing drugs out of reach from many who might potentially gain the maximum advantage.

MCUA has set a call out to people prosecuted or penalised for cannabis offenses dedicated for medical usage as 2016 to detail their experiences for use in an MCUA entry to the question.

“I want to use these instances as evidence that people with medical conditions are being forced to use black market and or to grow their own in order to get access to cannabis (at affordable prices),” stated MCUA’s Gail Hester.

The Senate committee to its question, directed by Greens leader Dr. Di Natale, is encouraging submissions from individuals, families and carers affected by medicinal cannabis regulations as they now stand in Australia.

The Medical Cannabis Users Association was set in 2014. Its duty is to work towards a fair, sustainable, affordable and suitable cannabis access model that’s patient centred, instead of industry concentrated and one which is predicated on a herbal instead of pharmaceutical version.